Best Peptides for Joint Health

1. BPC-157

BPC-157 is a 15-amino-acid partial sequence of body protection compound found in gastric juice. It is widely used in recovery protocols for its reported effects on tendon, ligament, muscle, and gut-lining repair. Mechanistically it is associated with upregulation of growth factor receptors and promotion of angiogenesis (new blood vessel formation), which supports tissue healing. It is frequently stacked with TB-500 for synergistic recovery and is a cornerstone of the healing-focused peptide protocol. Human clinical data is limited; most evidence is preclinical.

• Joint & Tendon Health (grade C) — rodent-model reviews plus a small human case series; no RCT
• Gut Health (grade C) — review of animal GI models (Sikiric 2020); no human trial
• Cognitive Function (grade C) — 1 cited study through 2013

Strongest study: interstitial cystitis open-label pilot, Altern Ther Health Med (2024) — open-label, uncontrolled, no placebo · intravesical 10 mg · 10/12 reported full symptom resolution (not an RCT) · N=12

Full BPC-157 reference

2. TB-500

TB-500 is a synthetic version of the active region of Thymosin Beta-4, a naturally occurring protein involved in cell migration, blood vessel formation, and tissue repair. It works systemically rather than locally, making it popular for whole-body recovery, muscle and tendon healing, and reducing stiffness. It upregulates actin, a protein central to cell movement and wound healing. TB-500 is most commonly paired with BPC-157 in healing blocks, where the two are seen as complementary — BPC-157 acting more locally and TB-500 systemically. Most evidence is preclinical or anecdotal.

• Joint & Tendon Health (grade D) — parent-molecule eye-drop trials only, and their phase 3s missed endpoints; no TB-500 human data

Strongest study: RegeneRx RGN-259 dry eye, Cornea (2019) — full-length Tβ4 eye drops, encouraging in early phase 2; later phase 3 trials (ARISE-3, SEER-1, SEER-3) missed · N=96

Full TB-500 reference

3. GHK-Cu

GHK-Cu is a naturally occurring copper-binding tripeptide whose plasma levels decline with age. It is best known for stimulating collagen and elastin production, improving skin firmness and wound healing, and supporting hair follicle health. It also has antioxidant and anti-inflammatory properties and has been studied for gene-expression effects associated with tissue remodeling. Available both as an injectable for systemic effects and topically for skin and hair. Often part of longevity and aesthetics protocols rather than performance stacks.

• Skin & Aesthetics (grade B) — large observational cosmetic literature; the two controlled trials missed objective endpoints
• Longevity (grade D) — 2026 C. elegans lifespan study, animal-only
• Joint & Tendon Health (grade D) — preclinical only (Fu 2015, rat ACL reconstruction)

Strongest study: Wen C. elegans lifespan, Biogerontology (2026) — mean lifespan extension via mitochondrial + DAF-16/SKN-1 regulation · C. elegans

Full GHK-Cu reference

4. KPV

KPV (Lysine-Proline-Valine) is a synthetic tripeptide corresponding to the C-terminal fragment of alpha-melanocyte-stimulating hormone (α-MSH), residues 11-13. It retains α-MSH's anti-inflammatory melanocortin signaling but, being only three amino acids, lacks the pigmentation-darkening and sexual-arousal effects seen with full-length analogs like Melanotan II. Research interest centers on gut inflammation, skin inflammation, and wound healing via modulation of the NF-κB pathway. It's sold only as a research compound — no clinical trial or FDA approval data exists.

Full KPV reference